Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter studyResearch in context

Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter studyResearch in context

Summary: Background: Frail elderly patients with newly diagnosed multiple myeloma (NDMM) have inferior survival and less benefit from high-dose therapies. This prospective study aimed to investigate the efficacy, safety, and quality of life (QoL) of induction treatment of ixazomib/lenalidomide/dexa...

Full description

Bibliographic Details
Main Authors: Li Bao, Yu-Tong Wang, Peng Liu, Min-Qiu Lu, Jun-Ling Zhuang, Mei Zhang, Zhong-Jun Xia, Zhen-Ling Li, Ying Yang, Zhen-Yu Yan, Hong-Mei Jing, Fei Dong, Wen-Ming Chen, Yin Wu, He-Bing Zhou, Rong Fu, Yu-Ping Gong, Wen-Rong Huang, Yong-Qing Zhang
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:EClinicalMedicine
Subjects:
Frail
Elderly
Multiple myeloma
All oral regimen
Quality of life
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537024000105

Internet

http://www.sciencedirect.com/science/article/pii/S2589537024000105

Similar Items